Mexico to Become Pharmaceutical Powerhouse: New Decree Spurs International Investment

Mexico Announces Decree to Boost Pharmaceutical Investment: A significant policy announcement from President Claudia Sheinbaum Pardo aims to transform Mexico's pharmaceutical industry. The decree, set to be published this week in the Diario Oficial de la Federación (DOF), will incentivize international pharmaceutical companies to invest in domestic medicine and medical supply production starting in 2026. This initiative is expected to create jobs and make medicines more affordable. "This investment will make medicines even more economical, and it will also generate employment," Sheinbaum stated during a press conference. The plan also includes collaboration with Mexican research institutions like Birmex, which has a history of vaccine production. This move positions Mexico to become a leader in the pharmaceutical sector, strengthening its healthcare system and economic prospects.